4//SEC Filing
KANTOFF AARON 4
Accession 0001578563-25-000201
CIK 0001534120other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:37 PM ET
Size
7.2 KB
Accession
0001578563-25-000201
Insider Transaction Report
Form 4
KANTOFF AARON
Director
Transactions
- Exercise/Conversion
Common Stock
2025-03-28+3,167→ 3,167 total - Exercise/Conversion
Restricted Stock Units
2025-03-28−3,167→ 6,333 total→ Common Stock (3,167 underlying)
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On August 13, 2024, the Reporting Person was granted 9,500 restricted stock units, vesting 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
Related Parties
1- filerCIK 0001862734
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 4:37 PM ET
- Size
- 7.2 KB